Actively Recruiting
MARPE-Associated Changes in Sleep and Airway
Led by Konya Necmettin Erbakan Üniversitesi · Updated on 2025-06-26
40
Participants Needed
1
Research Sites
14 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
At the beginning of MARPE treatment (T1) and at the end of the 3-month consolidation phase (T2), patients will complete the teen-STOP-BANG questionnaire and the Pittsburgh Sleep Quality Index (PSQI) to assess the potential benefit of MARPE in reducing the risk of obstructive sleep apnea syndrome (OSAS). Additionally, changes in the upper airway will be evaluated using CBCT images obtained at T1 and T2.
CONDITIONS
Official Title
MARPE-Associated Changes in Sleep and Airway
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Class I malocclusion
- Maxillary transverse deficiency
- Age between 15 and 18 years
- No systemic disease, cleft lip and palate, or speech disorders
- No history of prior orthodontic treatment
- Voluntary agreement to participate in the study
- Good oral hygiene
- ANB angle between 2° and 5°
You will not qualify if you...
- Presence of systemic diseases
- Smoking
- Poor oral hygiene
- Lack of cooperation
- Mental retardation
- Obesity or nutritional disorders
- Macroglossia or mandibular retrognathia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye), 42090
Actively Recruiting
Research Team
S
Seda Sağoğlu
CONTACT
K
Kazım K YILDIZ
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here